- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02449577
Identification of Biomarkers for Acute Intake of Beer and Alcohol and Acute Effects on Plasma and Insulin Response (METABEER)
Metabolomics in Beer Research: Identification of Biomarkers for Acute Intake of Beer and Alcohol in Individuals With a High or Low Habitual Intake, and Acute Effects on Plasma Glucose and Insulin Response Compared to Regular Soda
Study Overview
Status
Conditions
Intervention / Treatment
- Other: Beverage sequence ABCD
- Other: Beverage sequence CADB
- Other: Beverage sequence DACB
- Other: Beverage sequence CBAD
- Other: Beverage sequence ABDC
- Other: Beverage sequence DABC
- Other: Beverage sequence DCAB
- Other: Beverage sequence DBCA
- Other: Beverage sequence ADCB
- Other: Beverage sequence BADC
- Other: Beverage sequence ACDB
Detailed Description
The study is designed as a randomized, 4-way single-blinded cross-over intervention study. The participants are randomized individually to the order by which they shall receive 4 test meals. There will be implemented a standardized lunch which includes respectively 1) Light/alcohol-free (Tuborg Super Light 0,1% alcohol), 2) Regular lager (4,6% alcohol), 3) Strong beer(7,2% alcohol) and 4) a control drink without alcohol but with the same energy content (carbohydrate and protein) as the average of the other beverages ("sportsdrink"). Besides 330 ml of each test drink, each test meal consists of grilled cheese sandwiches (Tulip Food Company) and the amount of toast adjusted according to the type of drink served with each meal, so the content of macronutrients is the same in each meal.
The study includes 16-20 participants, randomized as to which order they will receive the 4 test meals with a washout period of at least 6 days in between test days. Upon arrival the test persons are asked to urinate (baseline sample), and at the 1st visit they are then weighed, height is measured and body composition (bioimpedance) is measured. After resting briefly, a baseline blood sample is taken and blood pressure is measured (1st and 4th visit). 45 minutes after start of the test meal the first postprandial blood sample is taken, and again after 45, 120 and 180 minutes. Urine is collected again at 0-90 min, 90-180 min and 3-24 hours after the test meal. Participants are provided with containers and equipment for this purpose, and must submit samples on an ongoing basis to the Dept. of Nutrition, Exercise and Sports.
Study Type
Enrollment (Actual)
Phase
- Early Phase 1
Contacts and Locations
Study Locations
-
-
-
Frederiksberg C, Denmark, 1958
- Department of Nutrition, Exercise and Sports, University of Copenhagen
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Healthy man or woman in the age group 18-60 years
- Likes and tolerates pasta, tomatoes and cheese, and is not a vegetarian or vegan, since meat (beef and pork) is included in the standardized dinner, breakfast and in the test meal
- Habitual alcohol intake (high: up to 7/14 units per week for women/men) or low: 0-2 units per week for both genders
- Tolerates alcohol
Exclusion Criteria:
- Systematic infections, psychiatric conditions and metabolic disease, and any clinical condition and other condition/situation, which according to the experimenter's assessment makes the person unfit to participate in the study
- Donation of a larger amount of blood (more than 24 ml) e.g. in connection with donation or other scientific research study, during the study and 3 months before start of the study
- Alcohol intake above the Danish Health and Medicines Authority's recommended 7 respective 14 drinks (units) per week for women and men
- Have or have had a drug addiction
- Allergy or intolerance to any of the tested drinks, or to any other foods included in the study. The participant will be specifically screened for possible alcohol allergy or intolerance
- Nursing, pregnancy or planned pregnancy.
- Not capable of complying with the procedures stipulated in the protocol.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Beverage sequence ABCD
Each participant randomized to this arm is exposed to 4 test meals in the order ABCD with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order ABCD
|
Experimental: Beverage sequence CADB
Each participant randomized to this arm is exposed to 4 test meals in the order CADB with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order CADB
|
Experimental: Beverage sequence DACB
Each participant randomized to this arm is exposed to 4 test meals in the order DACB with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order DACB
|
Experimental: Beverage sequence CBAD
Each participant randomized to this arm is exposed to 4 test meals in the order CBAD with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order CBAD
|
Experimental: Beverage sequence ABDC
Each participant randomized to this arm is exposed to 4 test meals in the order ABDC with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order ABDC
|
Experimental: Beverage sequence DABC
Each participant randomized to this arm is exposed to 4 test meals in the order DABC with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order DABC
|
Experimental: Beverage sequence DCAB
Each participant randomized to this arm is exposed to 4 test meals in the order DCAB with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order DCAB
|
Experimental: Beverage sequence DBCA
Each participant randomized to this arm is exposed to 4 test meals in the order DBCA with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order BDCA
|
Experimental: Beverage sequence ADCB
Each participant randomized to this arm is exposed to 4 test meals in the order ADCB with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order ADCB
|
Experimental: Beverage sequence BADC
Each participant randomized to this arm is exposed to 4 test meals in the order BADC with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order BADC
|
Experimental: Beverage sequence ACDB
Each participant randomized to this arm is exposed to 4 test meals in the order ACDB with a washout period of at least a week between each meal.
Each meal consisted of a standardized lunch of Parisian toast (sandwichbread, ham, cheese) together with a beverage.
Each beverage is assigned a letter, A, B, C, or D. The letter assignment is blinded.
The following four drinks were used Placebo: 330 ml of a soft drink (Sports drink), Beer 1 - 330 ml of an alcohol-free beer (<0.1% alcohol), Beer 2 - 330 ml of a regular lager beer (4.6% alcohol), and Beer 3 - 330 ml of a strong beer (7.2% alcohol)
|
Participants receive test beverages in the randomised order ACDB
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Area under the curve (AUC) for glucose
Time Frame: 0-180 minutes
|
Glucose is measured at 0, 45, 90, 120, and 180 min after the test meal and the area is determined by the trapezoid method.
|
0-180 minutes
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Area under the curve for insulin
Time Frame: 0-180 min
|
Insulin is measured at 0, 45, 90, 120, and 180 min after the test meal and the area is determined by the trapezoid method.
|
0-180 min
|
Plasma concentration of fatty acid ethyl esters (FAEE)
Time Frame: Change from 0-180min
|
Change in FAEE from baseline to 180min by LC-MS/MS analysis of plasma.
|
Change from 0-180min
|
Blood level of ethanol
Time Frame: 180 min
|
The amount of ethanol is measured via a breath test using an alcoholmeter.
|
180 min
|
Plasma beer metabolites (metabolic profiling with NMR and mass spectrometry).
Time Frame: After the intervention
|
Explorative marker to identify new beer intake-related metabolites in plasma.
|
After the intervention
|
Urinary content of paraaminobenzoic acid (PABA)
Time Frame: 24hour pooled urine from each volunteer
|
Total PABA metabolites by colorimetric assay to account for completeness of urine collection.
|
24hour pooled urine from each volunteer
|
Urinary content of ethyl glucuronide (EtG) and ethyl sulphate (EtS)
Time Frame: 0-24 hours
|
EtG and EtS by quantitative LC-MS/MS
|
0-24 hours
|
Blood content of ethyl glucuronide (EtG) and ethyl sulphate (EtS)
Time Frame: 0-180 min
|
EtG and EtS are measured at 0, 45, 90, 120 and 180 minutes and the difference between treatments is determined by multivariate ANOVA followed (if significantly different) by t-tests for each time point.
|
0-180 min
|
Urinary content of acetaldehyde (ethanal)
Time Frame: 0 -24 hrs
|
Ethanal is measured by a kit and compared between treatments.
|
0 -24 hrs
|
Urinary compounds of beer metabolites
Time Frame: 0-24 hrs
|
Metabolic profiling of urine by NMR and mass spectrometry.
|
0-24 hrs
|
Blood pressure
Time Frame: baseline and at time -30min on the last day of intervention.
|
Measurement of supine systolic and diastolic blood pressure
|
baseline and at time -30min on the last day of intervention.
|
Body fat mass and body fat percentage
Time Frame: baseline
|
Measurement of body fat mass and fat percentage by bioimpedance
|
baseline
|
Urinary creatinine
Time Frame: 0-24hrs
|
Creatinine is measured by standard clinical chemistry.
|
0-24hrs
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Lars O. Dragsted, Professor, Department of Nutrition, Exercise and Sports, University of Copenhagen, Rolighedsvej 30, 1958 Frederiksberg C, Denmark
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- M212
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insulin Resistance
-
Washington University School of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...CompletedEndoplasmic Reticulum Stress | HIV Related Insulin Resistance | Protease Inhibitor Related Insulin ResistanceUnited States
-
Paloma Almeda-ValdésCompleted
-
German Diabetes CenterYale UniversityRecruiting
-
National Institute of Diabetes and Digestive and...Active, not recruitingSevere Insulin ResistanceUnited States
-
Eunice Kennedy Shriver National Institute of Child...Completed
-
Assiut UniversityCompleted
-
National Taiwan UniversityNational Cheng-Kung University HospitalCompletedExercise, Insulin Resistance, Visceral Adipose TissueTaiwan
-
University Health Network, TorontoCompletedInsulin Resistance Syndrome X | Pancreatic Beta Cell FunctionCanada
-
The University of Texas Medical Branch, GalvestonCompletedInsulin Resistance, DiabetesUnited States
-
University Health Network, TorontoCompletedInsulin Resistance, DiabetesCanada
Clinical Trials on Beverage sequence ABCD
-
Temple UniversityJohns Hopkins University; Penn State University; Memorial Health University Medical...Completed
-
Chong Kun Dang PharmaceuticalUnknownHypertension | DyslipidemiasKorea, Republic of
-
Yuhan CorporationCompletedHealthyKorea, Republic of
-
University of Colorado, DenverJohnson & JohnsonCompleted
-
University of CopenhagenCompletedBiomarkers of Food Intake in Healthy Subjects
-
Centre Hospitalier Universitaire DijonRecruiting
-
Clinical Nutrition Research Centre, SingaporeCompletedObesity | Diabetes MellitusSingapore
-
Samyang Biopharmaceuticals CorporationCompletedHyperlipidemiaKorea, Republic of
-
Unilever R&DCompletedSatiety | AppetiteUnited Kingdom
-
University Hospital, LilleCompleted